Retrospective study of weekly paclitaxel-cetuximab (WPC) in unselected patients (p) with recurrent/metastatic head and neck squamous cell carcinoma (RM-SCCHN)

Autor:	N. Gimeno, C. Santander Lobera, R.A. Pazo Cid, Y. Llorente, A. Cebolleo de Miguel, M. Lanzuela Valero, Esther Millastre, J. Martinez Trufero, M. Alvarez Alejandro, A. Antón Torres, I. Pajares Bernad, M. Malo Yague, M.J. Agsustín, L. Calera Urquizu
Rok vydání:	2016
Předmět:	Oncology medicine.medical_specialty Cetuximab business.industry Weekly paclitaxel Retrospective cohort study Hematology medicine.disease Head and neck squamous-cell carcinoma Internal medicine Medicine business medicine.drug
Zdroj:	Annals of Oncology. 27:vi342
ISSN:	0923-7534
DOI:	10.1093/annonc/mdw376.43
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1f88cf366abfa35043a7d7b7a38f72d8 https://doi.org/10.1093/annonc/mdw376.43 Zobrazit plný text záznamu